Sotera Health has acquired Canada-based Iotron Industries, a provider of the electron beam (EBeam) for sterilisation of medical devices.
The financial terms of the transaction were not disclosed.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The acquired company has facilities in Indiana, British Columbia and Alberta.
Iotron is also known for its proprietary IMPELA accelerators, which offer high-powered EBeam processing for the sterilisation of medical devices and a range of industrial applications.
Sotera Health CEO Michael Petras Jr said: “While this acquisition expands our overall sterilisation footprint, it also enhances our EBeam capabilities and the strength of our offering to the market. We welcome Iotron’s management and the strong team as they join our mission of Safeguarding Global Health.”
Sotera Health expects the acquisition to expand its Sterigenics business.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSterigenics provides contract sterilisation and ionisation solutions for the medical device, pharmaceutical, food safety and high-performance materials industries. It specialises in Gamma, EtO, NO2, E-Beam and X-Ray sterilisation and has operations across 45 facilities in 13 countries.
Iotron Industries president and CEO Tino Pereira said: “I am exceedingly proud of the thriving business and expert team that we have built together at Iotron, and we all look forward to accelerating our growth as part of a global leader.
“Iotron and Sotera Health share common values around safety, customer focus, integrity, people and a commitment to excellence. We look forward to a brighter future together.”
US-based Sotera Health offers integrated health and sterilisation services to medical device, pharmaceutical, tissue and food industries.
